A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.

Detalles Bibliográficos
Autores principales: Nakamura, Naohiko, Kinami, Shinichi, Fujii, Yoritaka, Miura, Seiko, Fujita, Jun, Kaida, Daisuke, Tomita, Yasuto, Miyata, Takashi, Fujita, Hideto, Ueda, Nobuhiko, Kosaka, Takeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/
https://www.ncbi.nlm.nih.gov/pubmed/30997070
http://dx.doi.org/10.1002/ccr3.2056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/
https://www.ncbi.nlm.nih.gov/pubmed/30997070
http://dx.doi.org/10.1002/ccr3.2056

Ejemplares similares